Navigate Up
Sign In

National Antibiotic Committee

In November 2018 the National ​AMR Strategy was made available for Public Consultation: [link]​ The deadline for feedback submission was 9th December 2018. 
The final version ​​is now launched.

Law: 
The legal notice establishing and defining the terms of reference of 'The Committee' can be downloaded here.
Terms of Reference for the National Antibiotic Committee (NAC)

It shall be the duty of the Committee to:
 
(a) Promote the understanding of, and support for, correct prescribing, dispensing and use of antibiotics amongst medical, pharmaceutical and veterinary professionals as well as the public at large.
(b) Coordinate strategies to ensure the continued effectiveness of antibiotic agents used in the treatment and prevention of infectious diseases in humans and animals.
(c) Develop and recommend strategies to comply with directives and recommendations issued by the European Union on antibiotic use and resistance.
(d) Advise the Superintendent of Public Health on measures necessary to minimise antimicrobial resistance.
(e) Foster the development of written guidelines and recommendations for evidence-based use of antibiotics in both hospitals and community settings.
(f) React in a timely and realistic way to acute problems in the field of antimicrobial resistance as they arise.
(g) Keep abreast of the latest research and recommendations on antibiotic use and resistance and disseminate such information.
(h) Tender all such advice as may be requested by the Superintendent of Public Health.
 
The Committee shall undertake, delegate or coordinate:
 
  1. The establishment of surveillance systems to analyse trends in antibiotic resistance and use within hospitals as well as in the community.
  2. By virtue of the powers conferred by article 8 of the Public Health Act, the Committee shall act as an authorised body and collect, from any relevant entity, appropriate information concerning antibiotic resistance as well as data on the consumption, distribution and dispensing of antimicrobial agents used in the treatment and prevention of infections in humans and animals.
 
Members of the Committee:

Surname

Name

Title

Role (LN 122/2008)​​​

Date appointed

Appointment valid till:

Borg

Michael Angelo

Prof

Chairperson (1a)

28/06/2016

09/07/2021

Abela

Rodianne

Dr

Member (1b)

02/11/2018

09/07/2021

Melillo

Tanya

Dr

Member (1c)

28/06/2016

09/07/2021

Piscopo

Tonio

Dr

Member (1d)

28/06/2016

09/07/2021

Azzopardi

Anthony

Dr

Member (1e)

28/06/2016

09/07/2021

Formosa

Antonia

Ms

Member (1f)

28/06/2016

09/07/2021

Chircop

Susan

Dr

Member (1g)

​28/06/2016

09/07/2021

Zarb

Peter

Dr

Secretary (2)

28/06/2016

09/07/2021

  
  
  
  
There are no items to show in this view of the "Comments" discussion board.